Publications
21
Citations
348
Est. group size
—
Recurring co-author estimate
Active years
11
Publishing since 2014
Xue-Qi Tang's research spans two connected areas: the biology of chronic pain (especially neuropathic and cancer-related pain) and the study of natural plant compounds, such as those from Corni Fructus, for treating diabetes and metabolic disease. Earlier work examined how spinal cord immune cells (microglia) and signaling molecules like interleukin-10, β-endorphin, and GLP-1 receptor pathways reduce pain sensitivity in animal models. More recent work shifts toward analyzing herbal extracts and their bioactive components for managing diabetes, blood sugar, and insulin resistance, often using multi-omics and machine learning methods.
Publication output has been uneven over the last decade, with a peak in 2019, a lull around 2021-2022, and a recent resurgence in 2023-2024.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Correlation analysis between active components of Cornus officinalis and inorganic elements in rhizosphere soil and rapid analysis of origin quality by near-infrared spectroscopy combined with machine learning
Industrial Crops and Products · 2024
- The effect of glycation on the identification of characteristic tryptic peptides from porcine gelatin
Food Hydrocolloids · 2024
- Morroniside from corni fructus ameliorates type 2 diabetes in mice by regulating intestinal microbiota dysbiosis
Food Science and Human Wellness · 2024
- 1Comprehensive multi-omics analysis reveals the mechanism of loganin from Corni Fructus in improving insulin resistance in mice
Food Bioscience · 2024
- Nano powder and alcohol extraction of Corni Fructus protects against diabetes in mice by ameliorating hyperglycemic and hyperlipidemia via the PI3K/AKT pathway
Journal of Functional Foods · 2024
- Corni Fructus extracts ameliorate Streptozotocin-Induced diabetes in mice via regulating AMPK/ACC/CPT-1 signaling pathway
Journal of Functional Foods · 2023
- The GLP-1 receptor herbal agonist morroniside attenuates neuropathic pain via spinal microglial expression of IL-10 and β-endorphin
Biochemical and Biophysical Research Communications · 2020
- Dual μ-opioid receptor and norepinephrine reuptake mechanisms contribute to dezocine- and tapentadol-induced mechanical antiallodynia in cancer pain
European Journal of Pharmacology · 2020
- Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10/β-endorphin pathway
Journal of Neuroinflammation · 2019
- Spinal Interleukin-10/β-Endorphin Pathway Suppresses Neuropathic Pain in Infant Rats
Journal of Sun Yat-sen University · 2019
- Additional file 3: of Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10/β-endorphin pathway
Figshare · 2019
- Additional file 1: of Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10/β-endorphin pathway
Figshare · 2019
- Additional file 2: of Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10/β-endorphin pathway
Figshare · 2019
- Spinal interleukin-10 produces antinociception in neuropathy through microglial β-endorphin expression, separated from antineuroinflammation
Brain Behavior and Immunity · 2018
- Regulation of Gli2 stability by deubiquitinase OTUB2
Biochemical and Biophysical Research Communications · 2018
- Figshare×3
- Biochemical and Biophysical Research Communications×2
- Journal of Functional Foods×2
- Journal of Neuroscience×1
- Brain Behavior and Immunity×1
- Yun Guan
Medicine · The Ohio State University
- Jill C. Fehrenbacher
Medicine · Indiana University
- Jennifer Ritchie
Medicine · Indiana University
- Fletcher A. White
Medicine · Indiana University
- Carlos Henrique Alves Jesus
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile